Annovis Bio Inc (ANVS)
8.70
+0.34
(+4.07%)
USD |
NYSE |
May 15, 16:00
8.70
0.00 (0.00%)
After-Hours: 16:07
Annovis Bio Total Liabilities (Quarterly): 11.17M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.17M |
| December 31, 2023 | 17.96M |
| September 30, 2023 | 3.565M |
| June 30, 2023 | 2.074M |
| March 31, 2023 | 5.411M |
| December 31, 2022 | 7.698M |
| September 30, 2022 | 2.526M |
| June 30, 2022 | 1.299M |
| March 31, 2022 | 1.256M |
| December 31, 2021 | 1.506M |
| September 30, 2021 | 1.121M |
| Date | Value |
|---|---|
| June 30, 2021 | 0.8841M |
| March 31, 2021 | 1.597M |
| December 31, 2020 | 0.5784M |
| September 30, 2020 | 0.2811M |
| June 30, 2020 | 0.7029M |
| March 31, 2020 | 0.7493M |
| December 31, 2019 | 9.694M |
| September 30, 2019 | 8.755M |
| June 30, 2019 | 8.421M |
| March 31, 2019 | 8.207M |
| December 31, 2018 | 7.645M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.2811M
Minimum
Sep 2020
17.96M
Maximum
Dec 2023
4.362M
Average
1.835M
Median
Total Liabilities (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 107.35M |
| ANI Pharmaceuticals Inc | 437.71M |
| FibroGen Inc | 552.02M |
| Cerus Corp | 138.97M |
| Stereotaxis Inc | 19.99M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.813M |
| Shareholders Equity (Quarterly) | -3.354M |